"Placebo controlled multicenter trial" trang 1 - tải miễn phí từ tailieunhanh
Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: A multicenter double-blind placebo-controlled randomized trial

Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: A multicenter double-blind placebo-controlled randomized trial
5    55    1
Benefits of a fash dose of corticosteroids in digestive surgical oncology: A multicenter, randomized, double blind, placebo-controlled trial (CORTIFRENCH)

Benefits of a fash dose of corticosteroids in digestive surgical oncology: A multicenter, randomized, double blind, placebo-controlled trial (CORTIFRENCH)
9    1    1
Effects of Ghrelin Treatment on Exercise Capacity in Underweight COPD Patients: A substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment

Effects of Ghrelin Treatment on Exercise Capacity in Underweight COPD Patients: A substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
10    37    1
Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: Study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)

Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: Study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
9    57    0
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study): A multicenter randomized placebo controlled trial

Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study): A multicenter randomized placebo controlled trial
7    65    0
Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: A multicenter, randomized, placebo controlled trial (the MIDAS trial)

Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: A multicenter, randomized, placebo controlled trial (the MIDAS trial)
7    26    2
The ASAMET trial: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

The ASAMET trial: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
9    56    1
Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: Study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: Study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial
8    47    1